• Explore /
  • Poster
  • / PLATIPARP: A phase 2 study of induction docetaxel and carboplatin followed by maintenance rucaparib in treatment of patients with mCRPC with homologous recombination DNA repair deficiency.

PLATIPARP: A phase 2 study of induction docetaxel and carboplatin followed by maintenance rucaparib in treatment of patients with mCRPC with homologous recombination DNA repair deficiency.

Abstract Poster

Authors

null

Ruben Raychaudhuri

Fred Hutchinson Cancer Center, Seattle, WA

Ruben Raychaudhuri , Roman Gulati , Michael Thomas Schweizer , Todd Yezefski , Hiba M Khan , Evan Y. Yu , Peter Nelson , Colin C. Pritchard , Robert Bruce Montgomery , Heather H. Cheng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

NCT03442556

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 5052)

DOI

10.1200/JCO.2024.42.16_suppl.5052

Abstract #

5052

Poster Bd #

458

Abstract Disclosures

Similar Posters

First Author: Benedito A. Carneiro

First Author: Wassim Abida

First Author: Johann S. De Bono

First Author: Charles J. Ryan